Finzati - Logo
SPRO logo

Spero Therapeutics, Inc.

SPRO • Biotechnology
$1.25
▲ +0.03 (+2.46%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$72.46M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Stable or improving margins · 14.4%Positive revenue growth · 80.9%Reasonable earnings multiple · 15.23Manageable debt level · 0.05Healthy liquidity · 7.59
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:28 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.25
Change2.46%
Shares Out57.97M
Market Cap$72.46M
Enterprise Value$23.73M
52W Range1.08 - 3.08
Beta1.48
P/E4.28
P/S1.69
P/B1.64
P/FCF3.70
EV/Sales0.55

Investment DNA

How strong this company looks for long-term investors

65
out of 100
Business Quality
Margins, moat, returns
61/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
82/100
Why this score▼
Stable or improving margins · 14.4%Positive revenue growth · 80.9%Reasonable earnings multiple · 15.23Manageable debt level · 0.05Healthy liquidity · 7.59

Analyst view

Analyst sentiment and price target

SPRO
Analyst sentiment
Based on 13 analyst votes · 2026-10-20
65/100
Neutral
Bullish
6
Hold
5
Bearish
2

Company Overview

IPO: 11/2/2017
Industry: Biotechnology
P/B i: 1.64
Debt / Equity i: 0.05
Operating Margin: -0.04%
Net Margin: 14.38%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.05
Current Ratio: 7.59
Quick Ratio: 7.59
Status: Good

Insider Transactions

Recent executive and insider activity

Zack Debra
Transaction: 08/03/2026
OTHER
Change
0
Price
Not reported
Filing
08/06/2026
Type
OTHER
Zack Debra
Transaction: 08/03/2026
BUY
Change
+162,311
Price
Not reported
Filing
08/06/2026
Type
BUY
Zack Debra
Transaction: 08/03/2026
BUY
Change
+324,675
Price
$1.54
Filing
08/06/2026
Type
BUY